takeda_usa_pharmaceuticals_u

Takeda’s Entyvio secures Japanese approval in ulcerative colitis

July 2, 2018
Sales and Marketing Entyvio, Japan, Takeda, pharma, ulcerative colitis

Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio (vedolizumab), has been approved for the treatment of patients with moderately …

abbvie_0

AbbVie ordered to pay $448m over generic delays

July 2, 2018
Sales and Marketing AbbVie, FTC, androgel, besins, branded generics, pharma

A US Judge has ordered pharmaceutical company AbbVie to pay $448 million after determining that the company had used sham …

Novartis spins off Alcon as CEO focuses drug search

June 29, 2018
Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma

Novartis has announced a plan to spinoff Alcon โ€“ its eye care division โ€“ into a separately-traded standalone company.Novartis has …

Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis

June 29, 2018
Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis

Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …

NICE turns down Roche’s Ocrevus in early primary progressive multiple sclerosis

June 29, 2018
Medical Communications, Sales and Marketing NICE, Ocrevus, Roche, pharma

Rocheโ€™s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the formerโ€™s …

amazon

Amazon makes first move into healthcare with online pharmacy acquisition

June 28, 2018
Medical Communications, Sales and Marketing amazon, pharma, pharmacy

Itโ€™s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon …

baby-birth-born-161567

Ferring’s heat-stable drug could stop post-childbirth bleeding, WHO says

June 28, 2018
Research and Development Carbetocin, Ferring Pharmaceuticals, MSD, WHO, childbirth, pharma

A new formulation of a drug to prevent excessive bleeding in women after childbirth could save thousands of lives, says …

s_electronic_medical_record

Centralised EMR systems drive patient-physician relationships, report indicates

June 28, 2018
Medical Communications, Research and Development Electronic Medical Records, pharma

Advancement of IT within healthcare is transforming the dynamics of the patient-physician relationship and it is important to integrate various …

shutterstock_36423250

Summit Pharma axes Duchenne drug after Phase 2 failures

June 28, 2018
Research and Development Duchenne Muscular Dystrophy, Summit Pharmaceuticals, pharma, trial failure

Summit Therapeutics has revealed it is to terminate development of its Duchenne muscular dystrophy (DMD) drug ezutromid after it failed …

Roche’s Alecensa secures NICE approval in NSCLC after topping Pfizer’s Xalkori

June 28, 2018
Sales and Marketing Alecensa, NICE, NSCLC, Pfizer, Xalkori, pharma

UK health watchdog NICE has given its approval for Rocheโ€™s selective ALK inhibitor Alecensa (alectinib) for use on the NHS, …

amgen_hq

Amgen biosimilar proves non-inferior to J&J’s Remicade in rheumatoid arthritis

June 27, 2018
Research and Development, Sales and Marketing Amgen, Johnson & Jonson, Remicade, pharma, rheumatoid arthritis

Amgen has unveiled new Phase 3 data for its biosimilar version of Johnson & Johnsonโ€™s Remicade (infliximab), confirming that it …

shutterstock_95714119

US hospital’s ketamine study forced to a halt over consent concerns

June 27, 2018
Research and Development Hennepin Healthcare, Ketamine, pharma

Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …

abbvie_0

Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn

June 27, 2018
Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma

The partnership of Abbvie and Googleโ€™s Calico has announced they are to extend their existing 10-year drug discovery and development …

astrazeneca_building_white

AstraZeneca’s Lynparza proves efficacy in first-line BRCA-mutated advanced ovarian cancer

June 27, 2018
Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, Merck, ovarian cancer, pharma

AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line …

fdaoutsideweb

FDA panels vote to reject Pain Therapeutics’ abuse-deterrent opioid drug

June 27, 2018
Research and Development, Sales and Marketing Remoxy, opioid crisis, opioids, pain therapeutics, pharma

Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …

image_credit_roivant

Roivant launches two new companies amid major restructure and staff layoffs

June 26, 2018
Manufacturing and Production, Research and Development Roivant, pharma

Roivant, the global biopharmaceutical firm spearheaded by founder and CEO Vivek Ramaswamy (pictured), has announced it is to undergo a …

bi_microparts_image

Boehringer injects โ‚ฌ230 million in new Biologicals Development Center

June 26, 2018
Manufacturing and Production Boehringer Ingelheim, biologics, manufacturing, pharma

Prominent industry player Boehringer Ingelheim has unveiled plans to invest โ‚ฌ230 million into the construction of a new Biologicals Development …

save_our_nhs

NHS “below average” in treating eight most common causes of death, report says

June 26, 2018
Manufacturing and Production, Medical Communications NHS, pharma

The NHSโ€™s 70th birthday is again marked as a bittersweet one as a new report from the Nuffield Trust highlights …

pfizerbrussels_web

Pfizer’s Ibrance combo fails to improve overall survival in HER2- metastatic breast cancer

June 26, 2018
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Faslodex, Pfizer, breast cancer, ibrance, pharma

Pfizer has stumbled with the reveal of new data on the efficacy of its oral CDK 4/6 inhibitor Ibrance (palbociclib) in combination …

The Gateway to Local Adoption Series

Latest content